These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31970738)

  • 1. Imaging-guided percutaneous coronary intervention with ultra-low contrast angiographic control for patients at extreme risk of contrast induced nephropathy.
    Pyka Ł; Hawranek M; Wilczek K; Piegza J; Szkodzinski J; Lekston A; Gąsior M
    Cardiol J; 2019; 26(6):796-798. PubMed ID: 31970738
    [No Abstract]   [Full Text] [Related]  

  • 2. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
    Azzalini L; Laricchia A; Regazzoli D; Mitomo S; Hachinohe D; Bellini B; Demir OM; Poletti E; Maccagni D; Colombo A
    J Invasive Cardiol; 2019 Jun; 31(6):176-182. PubMed ID: 30865912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of intravascular ultrasound-guided drug-eluting stent implantation on patients with chronic kidney disease: Results from ULTIMATE trial.
    Zhang J; Gao X; Ge Z; Han L; Lu S; Qian X; Li Q; Lu Q; Chen C; Chen SL;
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1184-1193. PubMed ID: 31116913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated homocysteine and the risk of contrast-induced nephropathy: a cohort study.
    Barbieri L; Verdoia M; Schaffer A; Niccoli G; Perrone-Filardi P; Bellomo G; Marino P; Suryapranata H; Luca GD
    Angiology; 2015 Apr; 66(4):333-8. PubMed ID: 24830422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system.
    Gurm HS; Mavromatis K; Bertolet B; Kereiakes DJ; Amin AP; Shah AP; Hanzel GS; Rao S; Thomas JL; Kumar G
    Catheter Cardiovasc Interv; 2019 Jun; 93(7):1228-1235. PubMed ID: 30393942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimizing the risk of contrast-induced nephropathy and hemodynamic collapse during chronic total occlusion percutaneous coronary intervention with a percutaneous left ventricular assist device.
    Regazzoli D; Hachinohe D; Demir OM; Carlino M; Lemoine J; Mitomo S; Poletti E; Amor M; Colombo A; Azzalini L
    Cardiovasc Revasc Med; 2018 Sep; 19(6):712-716. PubMed ID: 29506964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center.
    Wolff G; Lin Y; Quade J; Bader S; Kosejian L; Brockmeyer M; Karathanos A; Parco C; Krieger T; Heinen Y; Perings S; Albert A; Icks A; Kelm M; Schulze V
    Clin Res Cardiol; 2020 Feb; 109(2):235-245. PubMed ID: 31236693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
    Shehata M; Hamza M
    Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery.
    Rahim HM; Flattery E; Gkargkoulas F; Maehara A; Mintz GS; Hardy MA; Cohen DJ; Dube GK; Crew RJ; Mohan S; Radhakrishnan J; Ratner LE; Moses JW; Ben-Yehuda O; Kirtane AJ; Stone GW; Leon MB; Karmpaliotis D; Ali ZA
    Coron Artery Dis; 2019 Aug; 30(5):346-351. PubMed ID: 31094895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention: A Subgroup Analysis of the PRESERVE Trial.
    Garcia S; Bhatt DL; Gallagher M; Jneid H; Kaufman J; Palevsky PM; Wu H; Weisbord SD;
    JACC Cardiovasc Interv; 2018 Nov; 11(22):2254-2261. PubMed ID: 30466822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedural Strategies to Reduce the Incidence of Contrast-Induced Acute Kidney Injury During Percutaneous Coronary Intervention.
    Almendarez M; Gurm HS; Mariani J; Montorfano M; Brilakis ES; Mehran R; Azzalini L
    JACC Cardiovasc Interv; 2019 Oct; 12(19):1877-1888. PubMed ID: 31521648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous intravenous infusion of nicorandil for 4 hours before and 24 hours after percutaneous coronary intervention protects against contrast-induced nephropathy in patients with poor renal function.
    Nawa T; Nishigaki K; Kinomura Y; Tanaka T; Yamada Y; Kawasaki M; Minatoguchi S
    Int J Cardiol; 2015 Sep; 195():228-34. PubMed ID: 26048382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bermuda triangle: Chronic kidney disease, contrast-induced nephropathy, and atrial fibrillation.
    Elserafy AS
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):72-74. PubMed ID: 29033366
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
    Rezaei Y; Khademvatani K; Rahimi B; Khoshfetrat M; Arjmand N; Seyyed-Mohammadzad MH
    J Am Heart Assoc; 2016 Mar; 5(3):e002919. PubMed ID: 27068631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Percutaneous Coronary Intervention During Non-ST-Segment-Elevation Myocardial Infarction in Elderly Patients With Chronic Kidney Disease.
    Holzmann MJ; Siddiqui AJ
    J Am Heart Assoc; 2020 Jun; 9(12):e015084. PubMed ID: 32519559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zero-contrast percutaneous coronary intervention on calcified lesions facilitated by rotational atherectomy.
    Karimi Galougahi K; Mintz GS; Karmpaliotis D; Ali ZA
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):E85-E89. PubMed ID: 28303645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
    Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
    BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
    Shema-Didi L; Kristal B; Eizenberg S; Marzuq N; Sussan M; Feldman-Idov Y; Ofir P; Atar S
    Nephrology (Carlton); 2016 Apr; 21(4):295-300. PubMed ID: 26370061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.